Martin Murphy
Director/Board Member bij BRII BIOSCIENCES LIMITED
Profiel
Martin J.
Murphy is the founder of CEO Roundtable on Cancer, Inc. He currently holds multiple positions including Chairman & Chief Executive Officer at AlphaMed Consulting, Inc., Director at the Foundation for the National Institutes of Health, Inc., Independent Non-Executive Director at Brii Biosciences Ltd., Independent Non-Executive Director at Brii Biosciences Ltd.
(China), Trustee at the American Cancer Society Foundation, and Scientific Advisor at Hatteras Venture Partners.
In the past, he served as President & Chief Executive Officer at Hipple Cancer Research Center, Chairman-Emeritus at the Conquer Cancer Foundation of the American Society of Clinical, Chairman-Scientific Advisory Board at Almac Diagnostic Services Ltd., Director at SillaJen Biotherapeutics, Inc., Director at Aldagen, Inc., Principal at C Change Surgical LLC, Advisory Board Member at Pappas Capital LLC, and Member-Board of Advisors at H.
Lee Moffitt Cancer Center & Research Institute, Inc. Dr. Murphy obtained a doctorate degree from Queen's University of Belfast in 2009 and graduate and doctorate degrees from New York University in 1967 and 1969 respectively.
Actieve functies van Martin Murphy
| Bedrijven | Functie | Begin |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Director/Board Member | 22-06-2021 |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Director/Board Member | - |
| AlphaMed Consulting, Inc. | Chief Executive Officer | 01-03-2003 |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Founder | - |
Foundation for the National Institutes of Health, Inc.
 Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Director/Board Member | - |
| American Cancer Society Foundation | Director/Board Member | 24-04-2009 |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Consultant / Advisor | - |
Eerdere bekende functies van Martin Murphy
| Bedrijven | Functie | Einde |
|---|---|---|
| Hipple Cancer Research Center | President | 01-01-1990 |
Aldagen, Inc.
 Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Chief Executive Officer | - |
| ░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Martin Murphy
| Queen's University of Belfast | Doctorate Degree |
| New York University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Bedrijven in privébezit | 14 |
|---|---|
C Change Surgical LLC
 C Change Surgical LLC Medical SpecialtiesHealth Technology C Change Surgical LLC designs and manufactures medical devices. It patents and markets computerized electronic systems that control sterile surgical fluid temperature. The company was founded by Patrick Kammer in 2004 and is headquartered in Winston-Salem, NC. | Health Technology |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
| American Cancer Society Foundation | |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Finance |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Commercial Services |
Foundation for the National Institutes of Health, Inc.
Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Commercial Services |
| Hipple Cancer Research Center | |
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA. | Commercial Services |
Almac Diagnostic Services Ltd.
 Almac Diagnostic Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The private company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004. | Commercial Services |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
| AlphaMed Consulting, Inc. |
